Tuodao Medical

Remote surgery planning, precise treatment, intelligent minimally invasive surgery … With the development of medical technology and the advancement of 5G communication technology, these cutting-edge and efficient means of diagnosis and treatment are coming into the operating room step by step to assist medical experts to cure patients.

Tuodao Medical settled in Nanjing’s Software Valley, though less than three years old, is a promoter of people’s well-being. Based on privileged professional background and strong R&D capability, Tuodao Medical is committed to innovation and continues to promote the high-quality development of technology-based medical cause.

With innovation blowing the trumpet, robots make surgery easier.

During the operation of twisting a screw with a diameter of 5-6 mm into the pedicle, which is about 8 mm wide or even narrower, and is surrounded by blood vessels, spinal cord and nerve roots, even the slightest mistake may bring about disastrous consequences. Such kind of spine surgeries is so difficult and risky that few surgeons are able to operate on them. So how could we solve the problem of limited high-quality medical resources and high surgical risks? Technology-based medical care opens up a new path.

In order to meet the clinical needs and follow the development direction of the industry, Tuoshou -Robotic System in Orthopaedic Surgery was born. Dr. Cheng Min, Chairman of Tuodao Medical said that “Tuoshou – Robotic System in Orthopaedic Surgery will not replace doctors, but serves as an ‘intelligent assistant’ to help doctors complete difficult surgeries accurately. Based on the mature AI technology matrix and precision machining process, Tuoshou realizes minimally invasive, precise and efficient spine surgery, solving the three major pain points in traditional surgery, which are ‘invisible, inaccurate and high radiation'”.

According to experts, in the global medical device field at present, surgical robots have the most complex technical requirements. It has both clinical value and commercial value. There is still a long way to go before we well develop China’s own surgical robots. Chang Jianbin, General Manager of Tuodao Medical, said that during the long-term development practice, Tuodao Medical has mastered multi-modal medical image fusion technology, robot precision control technology, optical spatial reconstruction and positioning and location tracking technology, which will form a wide technical moat. “Through the continuous transformation of scientific and technological achievements, Tuodao Medical aspires to be the ‘intelligent artisan’ to support medical experts. With remote healthcare based on 5G technology, surgeons could operate on patients thousands of miles away with the assistance of robots, which features high precision, small incisions and fast recovery. Patients can get out of bed in a day … This is the future medical scenarios we are working for.”

Presenting high quality and high efficiency, “surgical robots made in China” are striding forward.

In the world, there are some surgical robots at home and abroad that can also assist the treatment. However, according to the authoritative evaluation made by experts, Tuoshou – Robotic System in Orthopaedic Surgery has reached the international first-class level in terms of positioning accuracy and excellent rate of screw placement. The pace of promoting “surgical robots made in China” is accelerated.

Tuodao Medical shoulders the corporate mission of “making surgery easier and life healthier” and carries out the dedication to quality and safety in every detail of R&D and production with a highly responsible attitude to patients. Through multiple rounds of refined development, animal experiments and internal validation, the clinical trial success rate of Tuoshou – Robotic System in Orthopaedic Surgery has steadily reached 100%, which makes it the first company in China to complete a randomized controlled clinical trial with the similar orthopedic surgical robot.

Safety first, and efficiency should be equally highlighted. “We are a young company, less than three years old. In 2022, it is expected to put 2 products into commercial use, register 3 products for clinical trials, and initiate the pre-clinical development of 4 products”, Dr. Cheng Min said. Currently, Tuodao Medical has a R&D team of over 150 people and has developed a strategic layout in five major fields related to robotic system application, namely, orthopedic surgery, laparoscopic surgery, percutaneous puncture surgery, natural orifice transluminal endoscopic surgery and intraoperative medical imaging. “Tuodao Medical masters the core technology of surgical robots and strives to surpass international and domestic peer products in 5-10 years. At that time, surgical robots made in China will be common to see in the operating rooms of domestic hospitals.”

Look forward into the future and let more people enjoy high-quality healthcare.

Thanks to the development of artificial intelligence and 5G communication technology, the surgical robot industry is making a splash. According to Frost & Sullivan, a global growth consulting firm, the global surgical robot market will exceed RMB 100 billion in 2026, and the domestic market size will reach RMB 20 billion.

The blue ocean is right in front of us. It’s time to take steps and open up the future market. Dr. Cheng Min told us that Tuodao Medical will continue to apply intelligent technology to empower the future of medical care. They are determined to provide whole-process medical care and through-type solutions. They will always adhere to the corporate vision of “becoming a leader of China’s surgical robot industry and a top surgical robot company in China”. They will help the Chinese to firmly grasp the “scalpel” in our own hands, take the initiative to serve people with high-quality medical care and become the front-runner in the surgical robot industry! (Correspondent: Qu Xiaoli)